I-Fan Theodore Mau, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mau’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A84366 · Current
Licensed to practise in California · since 2003 · expires 2027-05-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Tennessee 42023Medical Doctor · since 2007 · expires 2009-05-31Specialty on the licence: OtolaryngologyVoluntarily RetiredNo board action on this licenceCheck it with the state
- Texas M8817Physician License · since 2008 · expires 2025-08-31Texas RetiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Harvard Medical School · MDBOSTON MA · 2002Medical school
Residency and fellowship
- Univ of California/General Surgery/InternshipSAN FRANCISCO CA · 2002–2003
- Univ of California/Otolaryngology/ResidencySAN FRANCISCO CA · from 2003
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$99,415
Medicare paid this office $99,415 for 212 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection of substance to augment voice box using an endoscope | 22 | $19,624 | $785 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 43 | $17,967 | $166 |
| Exam to assess movement of vocal cord flaps using an endoscope | 68 | $10,738 | $138 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | $9,973 | $91 |
| New patient visit (45+ min) | 47 | $5,440 | $116 |
See all 10 services
| Injection of substance to augment voice box using an endoscope | 22 | $19,624 | $785 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 43 | $17,967 | $166 |
| Exam to assess movement of vocal cord flaps using an endoscope | 68 | $10,738 | $138 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | $9,973 | $91 |
| New patient visit (45+ min) | 47 | $5,440 | $116 |
| Return visit (30+ min) | 36 | $4,814 | $94 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 11 | $3,308 | $195 |
| Short return visit (20+ min) | 43 | $3,103 | $62 |
| New patient visit (30+ min) | 26 | $2,098 | $81 |
| Botox | 33 | $753 | None |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
212 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 12% · Women 55% · Also on Medicaid 7% · Health risk score 1.53. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Coronary heart disease 33% · Diabetes 30% · COPD 27% · Depression 27% · Cancer 22% · Heart failure 20% · Chronic kidney disease 19% · Atrial fibrillation 19% · Stroke 10% · Dementia 6%.
The office billed $706,712, Medicare allowed $131,917 and paid $99,415; for 777 services of 34 kinds; $759 of it was for drugs given in the office and $98,656 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 212 | 777 | 74 | 1.53 | $706,712 | $99,415 |
| 2023 | 262 | 1,387 | 74 | 1.48 | $844,731 | $133,974 |
| 2022 | 195 | 1,039 | 73 | 1.43 | $655,273 | $102,584 |
| 2021 | 240 | 1,029 | 73 | 1.49 | $583,283 | $98,245 |
| 2020 | 220 | 912 | 73 | 1.46 | $516,533 | $89,489 |
| 2019 | 243 | 1,378 | 72 | 1.39 | $662,260 | $118,617 |
| 2018 | 251 | 1,243 | 71 | 1.44 | $519,263 | $102,264 |
| 2017 | 274 | 1,296 | 73 | 1.48 | $514,183 | $109,274 |
| 2016 | 284 | 1,230 | 71 | 1.59 | $421,448 | $98,641 |
| 2015 | 289 | 1,240 | 71 | 1.55 | $465,363 | $105,943 |
| 2014 | 266 | 1,078 | 71 | 1.46 | $385,383 | $94,144 |
| 2013 | 267 | 1,182 | 70 | 1.64 | $476,558 | $99,036 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Injection of substance to augment voice box using an endoscope | 21 | $21,262 | $886 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 46 | $20,820 | $171 |
| Exam to assess movement of vocal cord flaps using an endoscope | 107 | $19,182 | $146 |
| Diagnostic exam of voice box using a flexible endoscope | 85 | $11,874 | $96 |
| Injection of drug into side of voice box using an endoscope | 11 | $8,332 | $320 |
| New patient visit (45+ min) | 61 | $7,370 | $121 |
| Return visit (30+ min) | 49 | $6,962 | $90 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 18 | $5,128 | $205 |
| Short return visit (20+ min) | 51 | $3,991 | $68 |
| New patient visit (30+ min) | 41 | $3,421 | $83 |
| Botox | 55 | $2,532 | None |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 12 | $1,686 | $105 |
| Diagnostic exam of lung airway using an endoscope | 11 | $712 | $51 |
| Short return visit | 14 | $606 | $40 |
2022: 11 services
| Injection of chemical for paralysis of nerve muscles on side of voice box | 46 | $19,193 | $170 |
| Injection of substance to augment voice box using an endoscope | 17 | $17,740 | $986 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $10,668 | $96 |
| Removal or destruction of growth of side of voice box using an endoscope | 14 | $8,854 | $553 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 20 | $6,548 | $198 |
| Exam to assess movement of vocal cord flaps using an endoscope | 36 | $5,859 | $143 |
| New patient visit (45+ min) | 33 | $4,273 | $129 |
| Return visit (30+ min) | 29 | $4,138 | $99 |
| Botox | 52 | $1,934 | None |
| New patient visit (30+ min) | 21 | $1,642 | $78 |
| Short return visit (20+ min) | 23 | $1,510 | $63 |
2021: 11 services
| Injection of substance to augment voice box using an endoscope | 16 | $16,936 | $996 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 41 | $16,585 | $164 |
| Diagnostic exam of voice box using a flexible endoscope | 91 | $11,657 | $93 |
| Exam to assess movement of vocal cord flaps using an endoscope | 61 | $10,562 | $147 |
| Removal or destruction of growth of side of voice box using an endoscope | 11 | $7,172 | $478 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 18 | $4,183 | $199 |
| New patient visit (45+ min) | 35 | $3,978 | $114 |
| Return visit (30+ min) | 31 | $3,283 | $94 |
| New patient visit (30+ min) | 36 | $3,067 | $85 |
| Short return visit (20+ min) | 31 | $2,149 | $65 |
| Botox | 45 | $1,631 | None |
2020: 11 services
| Injection of chemical for paralysis of nerve muscles on side of voice box | 45 | $14,668 | $167 |
| Exam to assess movement of vocal cord flaps using an endoscope | 68 | $12,184 | $147 |
| Injection of substance to augment voice box using an endoscope | 12 | $11,357 | $874 |
| Removal or destruction of growth of side of voice box using an endoscope | 14 | $10,938 | $456 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | $8,028 | $82 |
| New patient visit (30+ min) | 55 | $4,519 | $82 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 15 | $3,874 | $204 |
| Return visit (30+ min) | 31 | $3,075 | $88 |
| Short return visit (20+ min) | 29 | $1,782 | $54 |
| Botox | 50 | $1,244 | None |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 11 | $1,101 | $79 |
2019: 10 services
| Injection of substance to augment voice box using an endoscope | 20 | $20,877 | $994 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 44 | $17,449 | $169 |
| Diagnostic exam of voice box using a flexible endoscope | 106 | $15,049 | $85 |
| Exam to assess movement of vocal cord flaps using an endoscope | 83 | $12,727 | $138 |
| Removal or destruction of growth of side of voice box using an endoscope | 14 | $7,533 | $377 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 27 | $6,327 | $192 |
| New patient visit (30+ min) | 72 | $5,838 | $81 |
| Short return visit (20+ min) | 64 | $4,281 | $57 |
| Botox | 46 | $2,637 | None |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 14 | $2,342 | $123 |
2018: 11 services
| Diagnostic exam of voice box using a flexible endoscope | 104 | $16,235 | $84 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 41 | $13,905 | $151 |
| Injection of substance to augment voice box using an endoscope | 12 | $13,559 | $1,043 |
| Exam to assess movement of vocal cord flaps using an endoscope | 83 | $12,540 | $129 |
| Injection of drug into side of voice box using an endoscope | 16 | $8,451 | $291 |
| New patient visit (30+ min) | 87 | $6,817 | $78 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 16 | $4,673 | $195 |
| Short return visit (20+ min) | 51 | $3,071 | $53 |
| Botox | 48 | $2,183 | None |
| Return visit (30+ min) | 22 | $1,897 | $86 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $483 | $40 |
2017: 8 services
| Injection of chemical for paralysis of nerve muscles on side of voice box | 40 | $18,355 | $185 |
| Exam to assess movement of vocal cord flaps using an endoscope | 112 | $17,064 | $131 |
| Diagnostic exam of voice box using a flexible endoscope | 114 | $15,980 | $79 |
| Injection of substance to augment voice box using an endoscope | 15 | $14,447 | $903 |
| New patient visit (30+ min) | 124 | $9,690 | $78 |
| Short return visit (20+ min) | 70 | $4,659 | $53 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 15 | $3,318 | $175 |
| Botox | 40 | $2,141 | None |
2016: 8 services
| Exam to assess movement of vocal cord flaps using an endoscope | 114 | $21,555 | $162 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 43 | $18,987 | $200 |
| Diagnostic exam of voice box using a flexible endoscope | 109 | $14,286 | $77 |
| Other procedure on voice box | 26 | $10,229 | $341 |
| New patient visit (30+ min) | 118 | $9,159 | $78 |
| Short return visit (20+ min) | 64 | $4,076 | $55 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 15 | $3,985 | $210 |
| Botox | 44 | $2,023 | None |
2015: 9 services
| Exam to assess movement of vocal cord flaps using an endoscope | 117 | $24,281 | $160 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 39 | $18,202 | $200 |
| Diagnostic exam of voice box using a flexible endoscope | 108 | $12,617 | $77 |
| Other procedure on voice box | 26 | $9,983 | $312 |
| New patient visit (30+ min) | 115 | $9,482 | $82 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 19 | $6,136 | $212 |
| Short return visit (20+ min) | 73 | $4,536 | $52 |
| Botox | 40 | $1,812 | None |
| Treatment of speech, language, voice, communication, and/or hearing processing disorder | 12 | $842 | $60 |
2014: 8 services
| Exam to assess movement of vocal cord flaps using an endoscope | 127 | $25,606 | $161 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 43 | $19,675 | $205 |
| Diagnostic exam of voice box using a flexible endoscope | 76 | $8,668 | $79 |
| New patient visit (30+ min) | 107 | $8,399 | $78 |
| Other procedure on voice box | 17 | $5,380 | $283 |
| Short return visit (20+ min) | 71 | $4,979 | $56 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 14 | $3,283 | $205 |
| Botox | 44 | $1,527 | None |
2013: 11 services
| Exam to assess movement of vocal cord flaps using an endoscope | 110 | $23,240 | $167 |
| Injection of chemical for destruction of neck muscles | 37 | $11,440 | $129 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $9,585 | $82 |
| New patient visit (30+ min) | 114 | $9,126 | $80 |
| Muscle electrical test | 32 | $4,594 | $60 |
| Other procedure on voice box | 14 | $3,791 | $271 |
| Short return visit (20+ min) | 61 | $3,763 | $50 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 12 | $3,203 | $214 |
| Botox | 37 | $1,556 | None |
| Evaluation of swallowing function image | 11 | $733 | $67 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $450 | $41 |
Drugs they prescribed that Part D paid
$1,183
Pharmacies billed $1,183 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 26% of their Part D prescriptions (19 of 72) in 2024. A higher opioid share than 9 in 10 peers; the typical otolaryngology clinician is at 4%.
69 generic and fewer than 11 brand-name prescriptions · $1,183 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Acetaminophen-Codeine | 18 | $82 | $5 |
| Diazepam | 13 | $11 | $1 |
Year by year
| 2024 | 72 | 44 | 26% (19) | None | $1,183 |
| 2023 | 94 | 49 | 43% (40) | None | $3,191 |
| 2022 | 65 | 38 | 49% (32) | None | $1,932 |
| 2021 | 62 | 41 | 34% (21) | None | $2,353 |
| 2020 | 78 | 44 | 24% (19) | None | $2,239 |
| 2019 | 110 | 59 | 33% (36) | None | $3,446 |
| 2018 | 113 | 43 | 21% (24) | 17% | $9,047 |
| 2017 | 128 | 51 | 31% (39) | 10% | $7,475 |
| 2016 | 87 | 42 | 24% (21) | 21% | $8,003 |
| 2015 | 90 | 38 | 24% (22) | 32% | $10,109 |
| 2014 | 111 | 41 | 17% (19) | 25% | $10,291 |
| 2013 | 80 | 32 | 25% (20) | 23% | $6,609 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Acetaminophen-Codeine | 36 | $108 | $3 |
| Prednisone | 12 | $36 | $3 |
2022: 1 drug
| Acetaminophen-Codeine | 31 | $155 | $5 |
2021: 2 drugs
| Acetaminophen-Codeine | 19 | $108 | $6 |
| Prednisone | 12 | $54 | $4 |
2020: 2 drugs
| Prednisone | 19 | $132 | $7 |
| Acetaminophen-Codeine | 15 | $57 | $4 |
2019: 3 drugs
| Acetaminophen-Codeine | 25 | $98 | $4 |
| Prednisone | 14 | $46 | $3 |
| Diazepam | 12 | $16 | $1 |
2018: 4 drugs
| Nexium | 12 | $6,109 | $509 |
| Propranolol | 11 | $318 | $29 |
| Methylprednisolone | 11 | $165 | $15 |
| Acetaminophen-Codeine | 21 | $96 | $5 |
2017: 4 drugs
| Nexium | 12 | $5,983 | $499 |
| Acetaminophen-Codeine | 21 | $96 | $5 |
| Hydrocodone-Acetaminophen | 17 | $72 | $4 |
| Diazepam | 13 | $35 | $3 |
2016: 2 drugs
| Nexium | 13 | $6,654 | $512 |
| Acetaminophen-Codeine | 16 | $84 | $5 |
2015: 2 drugs
| Nexium | 12 | $5,965 | $497 |
| Acetaminophen-Codeine | 15 | $48 | $3 |
2014: 3 drugs
| Nexium | 14 | $6,079 | $434 |
| Hydrocodone-Acetaminophen | 15 | $407 | $27 |
| Omeprazole | 22 | $215 | $10 |
2013: 2 drugs
| Nexium | 11 | $4,795 | $436 |
| Hydrocodone-Acetaminophen | 20 | $209 | $10 |
Money from drug and device companies
$114 in 2022
| 2022 | 1 | 1 | None | $114 |
| 2021 | 1 | 1 | None | $91 |
| 2020 | 1 | 1 | None | $23 |
| 2019 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Olympus America | Rhino-Laryngo Videoscope | $114 | 1 payment
|
See the published payment
| Olympus America | Meals · 2022-04-26 | Rhino-Laryngo Videoscope | $114 |
See earlier years (2021, 2020, 2019)
2021: $91
| Olympus America | Precautions of Using the Sterilization Cap | $91 | 1 payment
|
2020: $23
| Olympus America | Olympus Ent Fiber Scopes | $23 | 1 payment
|
2019: $119
| Olympus America | Olympus Capital Accessories | $119 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780718791
- Licence
- CA A84366, TN 42023, TX M8817California A84366: Current · expires 2027-05-31Tennessee 42023: Voluntarily RetiredTexas M8817: Texas Retired
- Trained
- Harvard Medical School, 2002
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-03-15
- NPI last updated
- 2025-07-01
- NPI record certified
- 2025-06-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 801 Welch Rd, Palo Alto, CA, 94304